Therapeutic options for postmenopausal female sexual dysfunction

被引:51
|
作者
Al-Azzawi, F. [1 ]
Bitzer, J. [2 ]
Brandenburg, U. [3 ]
Castelo-Branco, C. [4 ]
Graziottin, A. [5 ]
Kenemans, P. [6 ]
Lachowsky, M. [7 ]
Mimoun, S. [8 ]
Nappi, R. E. [9 ]
Palacios, S. [11 ]
Schwenkhagen, A. [10 ]
Studd, J. [12 ]
Wylie, K. [13 ]
Zahradnik, H. -P. [14 ]
机构
[1] Univ Hosp Leicester, Gynaecol Res Unit, Leicester, Leics, England
[2] Univ Basel Hosp, Dept Obstet & Gynecol, CH-4031 Basel, Switzerland
[3] Klin Psychiat & Psychotherapie, Aachen, Germany
[4] Univ Barcelona, Fac Med, Inst Clin Gynecol Obstet & Neonatol, Hosp Clin,IDIBAPS, Barcelona 7, Spain
[5] H San Raffaele Resnati, Ctr Gynecol & Med Sexol, Milan, Italy
[6] Free Univ Amsterdam, Med Ctr, Dept Obstet & Gynecol, Amsterdam, Netherlands
[7] Hop Xavier Bichat, Paris, France
[8] Robert Debre Hosp, Dept Obstet & Gynecol, Unit Psychosomat Gynecol, Paris, France
[9] Univ Pavia, IRCCS Maugeri Fdn, Res Ctr Reprod Med, I-27100 Pavia, Italy
[10] Ctr Gynecol Endocrinol & Reprod Med, Hamburg, Germany
[11] Inst Palacios Salud & Med Mujer, Madrid, Spain
[12] London PMS & Menopause Ctr, London, England
[13] Porterbrook Clin, Sheffield, S Yorkshire, England
[14] Univ Frauenklin, Klin Endokrinol & Reprod Med, Freiburg, Germany
关键词
FEMALE SEXUAL DYSFUNCTION; MENOPAUSE; ESTROGEN; TESTOSTERONE; DEFICIENCY; PSYCHOSOCIAL; SURGICALLY MENOPAUSAL WOMEN; QUALITY-OF-LIFE; DESIRE DISORDER; AROUSAL DISORDER; DOUBLE-BLIND; TESTOSTERONE PATCH; DEHYDROEPIANDROSTERONE REPLACEMENT; ESTROGEN THERAPY; UNITED-STATES; PREVALENCE;
D O I
10.3109/13697130903437615
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective To review the pharmacological and non-pharmacological therapies available for postmenopausal FSD, focusing on practical recommendations for managing postmenopausal women with sexual complaints, through a literature review of the most relevant publications in this field. Psychosocial therapy This type of therapy (basic counselling, physiotherapy and psychosexual intervention) is considered an adaptable step-by-step approach for diagnostic and therapeutic strategies, normally combined with biomedical interventions to provide optimal outcomes. Pharmacological therapy For postmenopausal FSD, many interventional options are now available, including hormonal therapies such as estrogens, testosterone, combined estrogen/testosterone, tibolone and dehydroepiandrosterone. Conclusions Menopause and its transition represent significant risk factors for the development of sexual dysfunction. FSD impacts greatly on a patient's quality of life. Consequently, it is receiving more attention thanks to the development of effective treatments. Non-pharmacological approaches should be used first, focusing on lifestyle and psychosexual therapy. If required, proven effective hormonal and non-hormonal therapeutic options are available.
引用
收藏
页码:103 / 120
页数:18
相关论文
共 50 条
  • [21] Future Targets for Female Sexual Dysfunction
    Farmer, Melissa
    Yoon, Hana
    Goldstein, Irwin
    JOURNAL OF SEXUAL MEDICINE, 2016, 13 (08): : 1147 - 1165
  • [22] Association of resilience with female sexual dysfunction
    Sood, Richa
    Mara, Kristin C.
    Vencill, Jennifer A.
    Kling, Juliana M.
    Faubion, Stephanie S.
    MATURITAS, 2024, 183
  • [23] Female Sexual Dysfunction
    Clayton, Anita H.
    Juarez, Elia Margarita Valladares
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 2017, 40 (02) : 267 - +
  • [24] Female sexual dysfunction
    Korda, J. B.
    UROLOGE, 2008, 47 (01): : 77 - 89
  • [25] Female Sexual Dysfunction
    Clayton, Anita H.
    Juarez, Elia Margarita Valladares
    MEDICAL CLINICS OF NORTH AMERICA, 2019, 103 (04) : 681 - +
  • [26] Assessing the Clinical Efficacy of Sildenafil for the Treatment of Female Sexual Dysfunction
    Brown, Dana A.
    Kyle, Jeffrey A.
    Ferrill, Mary J.
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (7-8) : 1275 - 1285
  • [27] Testosterone therapy and other treatment modalities for female sexual dysfunction
    Ingram, Catherine F.
    Payne, Kelly S.
    Messore, Marisa
    Scovell, Jason M.
    CURRENT OPINION IN UROLOGY, 2020, 30 (03) : 309 - 316
  • [28] Female Sexual Dysfunction: A Problem Hidden in the Shadows
    Imprialos, Konstantinos P.
    Koutsampasopoulos, Konstantinos
    Katsimardou, Aleksandra
    Bouloukou, Sofia
    Theodoulidis, Iakovos
    Themistoklis, Mikos
    Doumas, Michael
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (36) : 3762 - 3774
  • [29] Advances in pharmacotherapy for treating female sexual dysfunction
    Nappi, Rossella E.
    Cucinella, Laura
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (06) : 875 - 887
  • [30] Female sexual dysfunction (FSD): Prevalence and impact on quality of life (QoL)
    Nappi, Rossella E.
    Cucinella, Laura
    Martella, Silvia
    Rossi, Margherita
    Tiranini, Lara
    Martini, Ellis
    MATURITAS, 2016, 94 : 87 - 91